Second Generation Adeno-Associated Virus Type 2-based Gene Therapy Systems with the Potential for Preferential Integration into AAVS1
Journal:
Current Gene Therapy
Volume:
2
Page:
145-159
Author(s):
Roland A. Owens
Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
Journal:
Current Gene Therapy
Volume:
2
Page:
161-171
Author(s):
Peter Loser, Andreas Huser, Moritz Hillgenberg, Daniel Kumin, Gerald W. Both and Christian Hofimann
Regulation of T cell Apoptosis during the Immune Response
Journal:
Current Molecular Medicine
Volume:
2
Page:
257-272
Author(s):
Sven Baumann, Andreas Krueger, Sabine Kirchhoff and Peter H. Krammer
Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
403-417
Author(s):
E.S. White, R.M. Strieter and D.A. Arenberg
Recent Progress in the Development of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
419-439
Author(s):
Sandor Eckhardt
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Studies on the Mechanism of Action of Benzamide Riboside: A Novel Inhibitor of IMP Dehydrogenase
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
743-748
Author(s):
Kamran Gharehbaghi, Werner Grunberger and Hiremagalur N. Jayaram
Virally Encoded Polymerases as Targets for Chemotherapy: Application to HIV and HBV
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
1
Page:
99-117
Author(s):
George R. Painter, Karen Anderson, Martin Bouygues, Muriel Joubert and Dennis Liotta
Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
55-75
Author(s):
Angela casini, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran
Application of Phage Display Technology to Cancer Research
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
29-43
Author(s):
Yum L. Yip and Robyn L. Ward